Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups

D F Zaleznik1, M A Rench, S Hillier

  • 1Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Insights

Group B Streptococcus (GBS) caused invasive disease in newborns and pregnant women. Black or Hispanic race and low birth weight were linked to neonatal GBS, with serotypes Ia and III predominating.

Area of Science:

  • Neonatal infections
  • Obstetric infections
  • Bacterial pathogenesis

Background:

  • Group B Streptococcus (GBS) is a leading cause of invasive disease in neonates and pregnant women.
  • Surveillance data on GBS incidence and risk factors are crucial for public health interventions.
  • Understanding GBS serotype distribution aids in vaccine development and prevention strategies.

Purpose of the Study:

  • To describe the epidemiology of invasive GBS disease in neonates and peripartum women in the United States.
  • To identify risk factors associated with neonatal GBS infection.
  • To characterize the serotype distribution of GBS isolates from invasive infections.

Main Methods:

  • Prospective surveillance for invasive GBS disease in neonates (<7 days) and peripartum women.
  • Data collected from a diverse cohort across four US cities from 1993-1996.
  • Analysis of demographic factors, birth weight, and GBS serotypes.

Main Results:

  • 130 neonatal (0.8/1000 births) and 54 maternal (0.3/1000) cases identified.
  • Black or Hispanic race and birth weight <2500g were significant correlates of neonatal GBS.
  • Serotypes Ia and III predominated (34-37% and 25-26%, respectively), with type V also frequent (14-23%).

Conclusions:

  • Invasive GBS disease presented significant risks to neonates and peripartum women during 1993-1996.
  • Risk factors for neonatal GBS include race and low birth weight.
  • Predominant GBS serotypes Ia, III, and V inform prevention and vaccine efforts.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...